Evaluate treatment response and utilization in schizophrenia

patients followed longitudinally with deep clinical data


Evaluate the side-effects (including weight gain and other risk factors) and costs associated with use of second generation antipsychotics.


  • Evaluate patterns of select adverse effects and associated outcomes across pre-defined populations
  • Identified patients at higher risk for treatment-associated adverse clinical outcomes and higher costs